Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
National Institutes of Health Clinical Center (CC)
Hoffmann-La Roche
Endeavor Biomedicines, Inc.
ViroMissile, Inc.
Children's Oncology Group